期刊文献+

阿托伐他汀改善自发性高血压大鼠心室重构的机制 被引量:11

The Mechanism by Which Atorvastatin Improves Myocardial Remodeling in Spontaneously Hypertensive Rat
暂未订购
导出
摘要 目的研究阿托伐他汀(Ato)对自发性高血压大鼠(SHR)心室重构的作用,并探讨其作用机制。方法16周龄雄性SHR40只,随机分为4组,即SHR组、阿托伐他汀10mg组(Ato-1组)、25mg组(Ato-2组)和50mg组(Ato-3组)。Wistar-Kyoto(WKY)大鼠10只作为正常对照组(WKY组)。Ato-1组、Ato-2组和Ato-3组每日分别用阿托伐他汀10、25、50mg/kg灌胃。实验8周后,测定血液动力学指标,左室质量指数(LVMI),RT-PCR检测心肌转化生长因子β1(TGFβ1) mRNA、Smad3 mRNA和Smad7 mRNA。结果SHR组心室功能障碍,LVMI明显增高[(3.20±0.21)mg/g比WKY:(2.10±0.14)mg/g](P<0.01),心肌TGFβ1 mRNA(125.4±3.2比WKY:73.6±2.1,P<0.01)、Smad3 mRNA(6.40±0.43比WKY:3.10±0.75,P<0.01)增加,心肌Smad7 mRNA(2.30±0.86比WKY:4.10±1.23,P<0.01)降低。Ato呈剂量依赖性改善左室功能,降低SHRLVMI,降低心肌TGFβ1 mRNA、Smad3 mRNA,增加心肌Smad7 mRNA。结论阿托伐他汀可能通过下调心肌TGFβ1 mRNA、Smad3 mRNA和上调心肌Smad7 mRNA,改善SHR心室重构。 Objective The effect of atorvastatin on amelioration of ventricular remodel has been reported but the mechanism is not certain. This paper aimed to explore the mechanism by which atorvastatin(Ato) inhibites myocardial remodeling in spontaneously hypertensive rat (SHR). Methods Thirty 16-week old SHR were orally treated with different doses of Ato (10, 25 and 50 mg/kg) for 8 weeks. Untreated SHR( n= 10) and WKY( n= 10) rats were used as controls. The cardiac functions were determined in vivo at the end of the experiments and left ventricular mass index was calculated. The mRNA levels of transforming growth factor-β1 ( TGF-β1 ) and smad 3 and 7 subtypes in myocardial tissues were determined using RT-PCR. Results Significant deterioration in cardiac function and increase in left ventricular mass index in SHR(3. 20±0.21 mg/g) compared with those of WKY( 2. 10±0. 14 mg/g, P〈0. 01 ) were found. Furthermore, the level of TGF-β1 mRNA in myocardial tissues of SHR was significantly increased(SHR:125.4±3.2 vs WKY:73.6±2. 1), with increase in level of Smad 3 mRNA (SHR:6.40±0. 43 vs WKY:3. 10±0.75, P〈0.01) and decrease in level of Smad 7 mRNA(SHR:2. 30± 0. 86 vs WKY:4.10±1. 23, P〈0.01). Oral treatment with Ato for 8 weeks dose-dependently improve cardiac function and decrease left ventricular mass index. Moreover, atorvastatin markedly downregulate the levels of both TGF-β1 and Smad 3 and upregulate the level of Smad 7 mRNA. Conclusion Ato exert an inhibitory effect on myocardial remodeling in SHR, and such effect of Ato may be related to regulating TGF-β1/Smad signaling pathway.
出处 《中华高血压杂志》 CAS CSCD 北大核心 2007年第6期497-500,共4页 Chinese Journal of Hypertension
关键词 阿托伐他汀 高血压 心室重构 大鼠 转化生长因子Β1 SMAD Aatorvastatin Hypertension Myocardial remodeling Transforming growth factor-β1 Smad
  • 相关文献

参考文献13

  • 1[1]Nishikawa H,Miura S,Zhang B,et al.Statins induce the regression of left ventricular mass in patients with angina[J].Circ J,2004,68:121-125.
  • 2[2]Luo JD,Zhang WW,Zhang GP,et al.Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis[J].Clin Exp Pharmacol physiol,1999,26:903-908.
  • 3田建伟,赵连友,王士雯,张海涛,郑强荪,杨学东,徐琳,范延红.阿伐他汀对幼年大鼠心肌成纤维细胞增殖和胶原合成的影响及其意义[J].中华医学杂志,2003,83(2):118-122. 被引量:26
  • 4刘补尚,冷吉燕,付军.胰激肽原酶对自发性高血压大鼠心室重构的影响[J].中华高血压杂志,2006,14(11):887-890. 被引量:10
  • 5孙雅逊,胡申江,张志杰,康兰,赵晓燕,郑霞.阿托伐他汀改善自发性高血压大鼠的心肌脂质代谢和抑制心肌肥厚[J].中华高血压杂志,2006,14(8):632-635. 被引量:18
  • 6[6]Sun Y,Zhang J,Zhang JQ,et al.Local angiotensin Ⅱ and transforming growth factor betal in renal fibrosis of rats[J].Hypertens,2000,35:1078-1084.
  • 7[7]Sun Y,Zhang JQ,Zhang J,et al.Angiotensin transforming growth factor betal and repair in the infarcted heart[J].Mol Cell Cardio,1998,30:1559-1569.
  • 8[8]Hein S,Arnon E,Kostin S,et al.Progression from compensated hypertrophy to failure in the pressure overloaded human heart.Structural deterioration and compensatory mechanisms[J].Circulation,2003,107:984-991.
  • 9[9]Rosenkranz S,Flesch M,Amann K,et al.Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGFβ1[J].Am J Physiol Heart Circ Physiol,2002,283:1253-1262.
  • 10[10]Tomasek JJ,Gabbiani G,Hinz B,et al.Myofibroblasts and mechano-regulation of connective tissue remodelling[J].Nat Rev Mol Cell Biol,2002,3:349-363.

二级参考文献22

  • 1俞兆希,朱鹏立.人组织激肽释放酶基因应用于高血压治疗的研究进展[J].国外医学(老年医学分册),2005,26(2):72-76. 被引量:5
  • 2[1]Brandt JM,Djouadi F,Kelly DP.Fatty acids activate transcription of the muscle carnitine palmitoyltransferase Ⅰ gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha[J].J Biol Ihem,1998,273:23786-23792.
  • 3[2]Barger PM,Brandt JM,Leone TC,et al.Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth[J].J Clin Invest,2000,105:1723-1730.
  • 4[3]Michael N,Sack MD,Toni A,et al.Fatty acid oxidation enzyme gene expression is downregulated in the failing heart[J].Circulation,1996,94:2837-2842.
  • 5[5]Aoyama T,Peters JM,Iritani N,et al.Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α(PPAR α)[J].J Biol Chem,1998,273:5678-5684.
  • 6[6]Geneviève Martin,Hélène Duez,Christophe Blanquart,et al.Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-Ⅰ[J].J Clin Invest,2001,107:1423-1432.
  • 7[3]Ergul A,Portik-Dobos V,Ararat D,et al.Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation[J].American Journal of Physiology,2003,54:2225-2232.
  • 8[4]Agrotis A,Saltis J,Bobik A,et al.Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertension rats[J].Hypertension,1994,23:593-599.
  • 9[5]Francis G,Mytis LS,Brain RC,et al.Myocardial matrix degradation and metalloproteinase activation in the failing heart:A potential therapeutic target[J].Cardiovascular Research,2000,46:225-238.
  • 10[6]Silva JA Jr,Araujo RC,Baltatu O,et al.Reduced cardiac hypertrophy and altered blood pressure control in transgenic rats with the human tissue kallikrein gene[J].FASEB J,2000,14:1858-1860.

共引文献49

同被引文献110

引证文献11

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部